Blood biomarkers for the diagnosis of pre-clinical Alzheimer’s disease employing the Dominantly Inherited Alzheimer Network cohort [ 2017 - 2020 ]

Research Grant

Researchers: Prof Ralph Martins (Principal investigator) ,  A/Pr Mark Molloy ,  Prof Markus Wenk

Brief description Alzheimer’s disease (AD) is the most common form of dementia and yet a postmortem examination serves as the only definitive diagnosis. The current proposal seeks to investigate alterations in biochemical profiles of individuals who will develop Alzheimer’s disease due to an inherited mutation, against family members who are non-carriers of the mutation, to identify AD related blood changes which can contribute towards the development of a diagnostic blood test for the disease.

Funding Amount $AUD 1,153,505.43

Funding Scheme Project Grants

Notes Standard Project Grant